| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/25/2000 | US6017755 MADR2 tumour suppressor gene |
| 01/25/2000 | US6017748 Cloning host organisms |
| 01/25/2000 | US6017735 A fusion polypeptide having a herpes virus virion protein and a second protein selected from cell cycle control, suicide protein, antigenic sequences, immunomodulating or therapeutic protein; antiproliferative/anticarcinogenic agents |
| 01/25/2000 | US6017734 A hydrophobic nucleic acid sequence that targets the nuclear envelope polypeptides of heterologous cellular membrane proteins; insecticides |
| 01/25/2000 | US6017731 Nucleotide sequences encoding a signal sequence, a propeptide leader sequence, a preferred processing site cleaved in situ by a yeast proteolytic enzyme; expressing mammalian proteins and their secretion in a biologically active mature form |
| 01/25/2000 | US6017730 Method of limiting the survival of genetically engineered microorganisms in their environment |
| 01/25/2000 | US6017729 Receptor activator of NF-κB |
| 01/25/2000 | US6017728 ribH |
| 01/25/2000 | US6017727 Syndecan enhancer element and syndecan stimulation of cellular differentiation |
| 01/25/2000 | US6017719 Targeting cells from heterogeneous suspension; forming cell complexes linked to antibody bound to surface antigen, separating complexes, mixing antibody with peptide that binds and displaces antibody from antigen, releasing target cell |
| 01/25/2000 | US6017717 Human thymosin β15 gene, protein and uses thereof |
| 01/25/2000 | US6017716 Mixing biological sample with an isolated protein and determining binding of antibodies in sample to protein; antibody binding idicates melanoma |
| 01/25/2000 | US6017714 Netrins |
| 01/25/2000 | US6017710 A nucleic acid molecule that codes for a g-protein polypeptide; diagnosis and therapy; anticarcinogenic and antitumor agents |
| 01/25/2000 | US6017705 Nucleic acid molecules that codes for tumor rejection antigens; diagnosis and screening for possible presence of lymphoma, or head and neck squamous cell carcinoma, skin and mammary carcinomas |
| 01/25/2000 | US6017697 Excitatory amino acid receptor protein and related nucleic acid compounds |
| 01/25/2000 | US6017695 A polynucleotide sequence that encodes a human brain glycoprotein, contactin; to study signal transmissions, cell morphology, cell metabolism and cell adhesion |
| 01/25/2000 | US6017692 Methods of detecting a malignant cell in a biological sample comprising measuring Mxi gene expression alterations |
| 01/25/2000 | US6017544 Isolating stress protein-peptide complex from tumor cells previously removed from a mammal and administering the isolated stress protein-peptide complex along with a cytokine to the mammal in order to stimulate an immune response |
| 01/25/2000 | US6017543 Outer envelope free viral preparation for use in vaccination against and immunotherapy of human immunodeficiency virus |
| 01/25/2000 | US6017542 Nucleotide and amino acid sequences of canine herpesvirus GD and uses therefor |
| 01/25/2000 | US6017539 Multimeric hybrid genes encoding corresponding chimeric protein comprise gene sequence coding for antigenic region of protein from first pathogen linked to gene sequence coding for antigenic region of protein from second pathogen |
| 01/25/2000 | US6017538 Plasmodium falciparum antigens inducing protective antibodies |
| 01/25/2000 | US6017536 Simian immunodeficiency virus peptides with antifusogenic and antiviral activities |
| 01/25/2000 | US6017535 cDNA sequence of Dengue virus serotype 1 (Singapore strain) |
| 01/25/2000 | US6017534 Development of transgenic plants which express broad-spectrum insecticidal activity against a variety of flies, moths and beetles; chimeric crystal delta-endotoxins having improved insecticidal properties and broad-range specificities |
| 01/25/2000 | US6017533 Assessing the signal transduction ability of pacap type 1 receptor-expressing cells in a mammalian tissue by contacting them with an agonist/antagonist peptide and assaying the affinity |
| 01/25/2000 | US6017527 Activated dendritic cells and methods for their activation |
| 01/25/2000 | US6017524 Inhibiting the growth p53 deficient tumor cells by administering the p53 gene |
| 01/25/2000 | US6017523 Treating a immunodeficiency, hematopoietic or bone marrow disorder ;stimulants; anticarcinogenic agents; side effect reduction; muteins having several variations, preferably in one to three amino acids |
| 01/25/2000 | US6017512 Cyclic hexapeptides not comprised of a disulfide bond covalently linked to a radiolabel e.g. technetium; scintigraphic imaging agents; radiodiagnosis and -therapy; antitumor,-carcinogenic and -diabetic agents; stability |
| 01/25/2000 | US6017510 Radioisotope of technetium-99m labeled leukocyte-binding peptides; scintographic imaging of sites of infection and inflammation; peptide derived from platelet factor 4, a bacterially-derived chemotactic peptide, fibrinopeptide |
| 01/25/2000 | US6017509 Cyclic hexapeptides not comprised of a disulfide bond covalently linked to a radiolabel e.g. technetium; scintigraphic imaging agents; radiodiagnosis and -therapy; antitumor,-carcinogenic and -diabetic agents; stability |
| 01/25/2000 | CA2190268C Sterile and pyrogen-free columns coupled to protein for binding and removal of substances from blood |
| 01/25/2000 | CA2145859C Bacillus thuringiensis cryet4 and cryet5 toxin genes and proteins toxic to lepidopteran insects |
| 01/25/2000 | CA2027629C Glycopeptide antibiotics |
| 01/25/2000 | CA1340880C Cancer-related antigen-specific human immunoglobulins and human/human hybridomas having the ability to produce said human immunoglobulins |
| 01/25/2000 | CA1340879C Recombinant dna product and methods |
| 01/25/2000 | CA1340878C Production of human t-cell leukemia (lymphotropic) retrovirus (htlv-i) envelope protein fragments in bacteria and use in seroepidemiological survey of human lymphoid malignancies |
| 01/20/2000 | WO2000003248A1 Method for identifying a presenilinase inhibitor |
| 01/20/2000 | WO2000003029A2 Chimaeric adenoviruses |
| 01/20/2000 | WO2000003028A2 Method for optimizing the production of adenovirus vectors |
| 01/20/2000 | WO2000003027A1 Method for improving the gene transfer of genetic material in mammalian cells through the use of p21 (waf-1) |
| 01/20/2000 | WO2000003026A2 Transcription coactivators |
| 01/20/2000 | WO2000003025A2 Method of genetic modification of a wild type viral sequence |
| 01/20/2000 | WO2000003024A2 Alleles of the human mu opioid receptor, diagnostic methods using said alleles, and methods of treatment based thereon |
| 01/20/2000 | WO2000003023A1 Usurpin, a mammalian ded-caspase homologue that precludes caspase-8 recruitment and activation by the cd-95 (fas, apo-1) receptor complex |
| 01/20/2000 | WO2000003019A1 Conditional mutants of influenza virus m2 protein |
| 01/20/2000 | WO2000003018A2 Antibiotic protein and method of production |
| 01/20/2000 | WO2000003017A2 Enhancer elements for increased translation in plant plastids |
| 01/20/2000 | WO2000003015A2 Human transport protein homologs |
| 01/20/2000 | WO2000003013A2 Gene and protein involved in liver regeneration |
| 01/20/2000 | WO2000003012A2 Expression of eukaryotic peptides in plant plastids |
| 01/20/2000 | WO2000003011A2 METHOD FOR PRODUCING A PEPTIDE WITH A pI ABOVE 8 OR BELOW 5 |
| 01/20/2000 | WO2000003010A2 Protein secretion from bacteria having reduced expression of a product encoded by the dlt operon |
| 01/20/2000 | WO2000003009A2 Genes for the biosynthesis of anticapsin and bacilysine, their isolation and their use |
| 01/20/2000 | WO2000003003A2 Screening of neisserial vaccine candidates and vaccines against pathogenic neisseria |
| 01/20/2000 | WO2000002997A2 Transgenic mouse expressing green fluorescent protein in astrocytes |
| 01/20/2000 | WO2000002996A2 Recombinant constructs and systems for secretion of proteins via type iii secretion systems |
| 01/20/2000 | WO2000002924A1 Papillomavirus cellular receptor |
| 01/20/2000 | WO2000002921A1 Method for purifying hemoglobin |
| 01/20/2000 | WO2000002920A1 Inhibition of lipoprotein formation |
| 01/20/2000 | WO2000002919A1 Growth hormone secretagogue related receptors and nucleic acids |
| 01/20/2000 | WO2000002918A1 Mouse growth hormone secretagogue receptor |
| 01/20/2000 | WO2000002917A2 Compounds and methods for modulating cadherin-mediated functions |
| 01/20/2000 | WO2000002916A2 PEPTIDE COMPOSITIONS MIMICKING TGF-β ACTIVITY |
| 01/20/2000 | WO2000002915A1 Compound capable of inhibiting the binding of a protein to mast cells, use of the compound for the preparation of a drug, a pharmaceutical composition, a method of diagnosing a disease, and a method of selection |
| 01/20/2000 | WO2000002914A1 Modified proteins |
| 01/20/2000 | WO2000002913A1 Chemotaxis-inhibiting protein of staphylococcus (chips) and its use |
| 01/20/2000 | WO2000002911A2 INTERACTION OF HUMAN BETA AMYLOID PRECURSOR PROTEIN (β-APP) WITH HUMAN LON-PROTEASE LIKE PROTEIN (HSLON) |
| 01/20/2000 | WO2000002910A2 Human fast-1 gene |
| 01/20/2000 | WO2000002909A2 Amphiphilic peptides derived from the cytoplasmic tail of viral envelope proteins |
| 01/20/2000 | WO2000002907A1 Tumor antigen peptide originating in sart-1 |
| 01/20/2000 | WO2000002903A1 Cs-1 peptidomimetics, compositions and methods of using the same |
| 01/20/2000 | WO2000002902A1 Novel inhibitors of angiogenesis and tumor growth |
| 01/20/2000 | WO2000002900A1 Method for the production of recombinant peptides with a low amount of trisulfides |
| 01/20/2000 | WO2000002899A1 Method of using an improved peptide nucleic acid universal library to optimize dna sequence hybridation |
| 01/20/2000 | WO2000002897A2 Delta cleavage products and methods based thereon |
| 01/20/2000 | WO2000002864A1 Precusors for pna-monomers |
| 01/20/2000 | WO2000002860A1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them |
| 01/20/2000 | WO2000002589A1 Modulation of haemopoietic cell activity and agents useful for same |
| 01/20/2000 | WO2000002575A1 Prion protein and uses thereof |
| 01/20/2000 | WO2000002524A2 Botulinum neurotoxin vaccine |
| 01/20/2000 | WO2000002523A2 Vaccine against staphylococcus intoxication |
| 01/20/2000 | WO2000002522A2 Anthrax vaccine |
| 01/20/2000 | WO1999060117A3 Prax-1 polypeptide |
| 01/20/2000 | WO1999059627A3 Verotoxin b subunit for immunization |
| 01/20/2000 | WO1999058978A3 Tumour markers |
| 01/20/2000 | WO1999058676A3 Semaphorin polypeptides |
| 01/20/2000 | WO1999058659A3 Methods and compositions for expression of transgenes in plants |
| 01/20/2000 | WO1999058641A8 Nt2lp, novel g-protein coupled receptors having homology to neurotensin-2 receptors |
| 01/20/2000 | WO1999058560A3 Prostapin gene and protein and uses thereof |
| 01/20/2000 | WO1999058559A3 Factors affecting tumor necrosis factor receptor releasing enzyme activity |
| 01/20/2000 | WO1999057273A3 Cytoplasmic antiproteinase-3 coding sequence in gene therapy |
| 01/20/2000 | WO1999057145A3 Human bmp-4 promoter and method for exploring bone-related substance by using the same |
| 01/20/2000 | WO1999054954A3 Cd4 radio-immunological pharmaceuticals for the treatment of hiv infections |
| 01/20/2000 | WO1999053067A8 Seed-coat promoters, genes and gene products |
| 01/20/2000 | WO1999053052A3 Srebp-2-deficient cell lines |
| 01/20/2000 | WO1999051742A3 Dadd, death activator death domain protein |
| 01/20/2000 | WO1999050289A3 Transformation progression-related genes and their use |